Action of antitumoral platinum complexes on in vitro platelet functions

Rosemberg, 1980 Farrell, 1989, 1 Loehrer, 1984, Drugs five years later. Cisplatin, Ann. Intern. Med., 100, 704, 10.7326/0003-4819-100-5-704 Petsko, 1995, Cancer therapy: heavy metal revival, Nature, 377, 580, 10.1038/377580a0 Weiss, 1982, The renal toxicity of cancer chemotherapeutic agents, Cancer Treat. Rev., 9, 37, 10.1016/S0305-7372(82)80004-2 Comess, 1993, 1, 134 Roth, 1988, Cisplatin-based combination chemotherapy for disseminated germ cell tumours: long term follow up, J. Clin. Oncol., 6, 1239, 10.1200/JCO.1988.6.8.1239 Fields, 1989, Thrombotic microangiopathy associated with chemotherapy: case report and review of the literature, DCIP: Ann. Pharmacother., 23, 582 Yen, 1993, Cisplatin-induced platelet activation requires mononuclear cells: role of GMP-140 and modulation of procoagulant activity, Br. J. Haematol., 83, 259, 10.1111/j.1365-2141.1993.tb08281.x Perez, 1994, Phase I study of high-dose cisplatin, ifosfamide and etoposide, Cancer Chemother. Pharmacol., 34, 331, 10.1007/BF00686041 Lund, 1989, High dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease, J. Clin. Oncol., 7, 1469, 10.1200/JCO.1989.7.10.1469 Weiss, 1993, New cisplatinum analogues in development, Drugs, 46, 360, 10.2165/00003495-199346030-00003 Onho, 1993, Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats, Br. J. Cancer, 68, 469, 10.1038/bjc.1993.372 Panella, 1990, Platelets acquire a secretion defect after high-dose therapy, Cancer, 65, 1711, 10.1002/1097-0142(19900415)65:8<1711::AID-CNCR2820650808>3.0.CO;2-W Kubisz, 1982, Influence of cisplatinum on some platelet functions in vitro, Neoplasia, 30, 391 Karolak, 1992, High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathways, Mol. Pharmacol., 43, 37 Doni, 1988, Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses, Biochem. Biophys. Res. Commun., 156, 1316, 10.1016/S0006-291X(88)80776-9 Francesconi, 1995, Type IIB von Willebrand Factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets, Biochem. Biophys. Res. Commun., 214, 102, 10.1006/bbrc.1995.2262 Pollock, 1986, Thrombin and ionomycin can rise platelet cytosolic Ca2+ to micromolar level by discharge of internal stores: studies using fura-2, Biochem. Biophys. Res. Commun., 139, 308, 10.1016/S0006-291X(86)80114-0 Lapetina, 1985, Thrombin induces serotonin secretion and aggregation independently of inositol phospholipid hydrolysis and protein phosphorylation in human platelets permeabilized with saponin, J. Biol. Chem., 260, 7078, 10.1016/S0021-9258(18)88890-1 Deana, 1989, Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate, Biochim. Biophys. Acta, 1014, 203, 10.1016/0167-4889(89)90035-9 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 Sune, 1988, Relationship between the tranverse distribution of phospholipids in plasma membrane and shape change of human platelets, Biochemistry, 27, 6794, 10.1021/bi00418a022 Harkness, 1981, Measurement of plasma viscosity, 79 Siess, 1989, Molecular mechanisms of platelet activation, Physiol. Rev., 69, 58, 10.1152/physrev.1989.69.1.58 Odenhamer, 1982, Reactions of cisplatin with sulfur containing aminoacids and peptides, Inorg. Chim. Acta, 66, 41, 10.1016/S0020-1693(00)85769-2 Wachowicz, 1993, Inhibitory effect of cisplatin on the enzymic peroxidation of platelet endogenous arachidonate, Cytobios, 75, 157 Wachowicz, 1995, Effects of cisplatin and selenite on the level of thiols in pig blood platelets, J. Physiol. Pharmacol., 46, 97 Olas, 1996, Cisplatin-induced changes in biological activity of blood platelets: thiol-related mechanisms, Anti-cancer Drugs, 7, 476, 10.1097/00001813-199606000-00013 Olas, 1997, Effect of granulocyte colony stimulating factor on pig blood platelets treated with cisplatin in vitro, Anti-cancer Drugs, 8, 204, 10.1097/00001813-199702000-00012 Luzzato, 1990, The prethrombotic state in cancer, Semin. Oncol., 17, 147 Weiss, 1981, Venous thrombosis during multinodal treatment of primary breast carcinoma, Cancer Treat. Reports, 65, 677 Seiffer, 1985, Deep vein thrombosis during therapy for Hodgkin’s disease, Cancer Treat. Reports, 69, 1011 Levine, 1988, The thrombogenic effect of drug treatment in women with stage II breast cancer, New Engl. J. Med., 318, 404, 10.1056/NEJM198802183180703 Maines, 1990, Effect of cis-platinum on heme, drug and steroid metabolism pathway: possible involvement in nephrotoxicity and infertility, Toxicology, 21, 1 Grignani, 1990, Interactions of platelets and tumor cells, 93 Honn, 1992, Platelets and the cancer metastasis more than epiphenomenon, Semin. Thromb. Hemost., 4, 392, 10.1055/s-2007-1002578 Dalla Via, 1996, Correlation between cytosolic Ca2+ concentration, protein phosphorylation and platelet secretion, Cell Calcium, 20, 431, 10.1016/S0143-4160(96)90006-8 Blackshear, 1988, Protein kinases 1988: a current perspective, FASEB J., 2, 2957, 10.1096/fasebj.2.14.2972578 Van Hoof, 1996, Protein phosphatases, 329 Rittenhouse, 1985, Mass changes in myoinositol trisphosphate in human platelets stimulated by thrombin. Inhibitory effects of phorbol ester, J. Biol. Chem., 260, 8657, 10.1016/S0021-9258(17)39396-1 Ruzzene, 1992, Inhibition of thrombin-induced platelet activation by dioctanoylglycerol pretreatment is not correlated with the 47 kDa protein phosphorylation, Sec. Messeng. Phosphoprot., 14, 11